Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China Resources Life Sciences (CRLS) is a strategic business unit of China Resources Group, a Fortune Global 500 state-owned conglomerate. Headquartered in Beijing, the company functions as an integrated platform for the research, development, and industrialization of cutting-edge life science technologies. Its core operations focus on five key areas: cell and gene therapy, aerospace medicine, precision medicine, medical devices, and health management. CRLS operates the China Resources Life Sciences Park, which serves as a major hub for high-tech incubation and GMP manufacturing, facilitating the transition of scientific breakthroughs into clinical and commercial applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on China Resources Life Sciences.